Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
Full-length VAR2CSA is a potential placental malaria vaccine candidate and in this study, Renn et al. compare antigenicity and receptor binding affinity of different allelic variants in blood samples from pregnant women. Their data show that inter-allelic differences may contribute to the heterogene...
Guardado en:
Autores principales: | Jonathan P. Renn, Justin Y. A. Doritchamou, Bergeline C. Nguemwo Tentokam, Robert D. Morrison, Matthew V. Cowles, Martin Burkhardt, Rui Ma, Niraj H. Tolia, Michal Fried, Patrick E. Duffy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9468370d9ab9416c980d5d735228618e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
por: Marion Avril, et al.
Publicado: (2011) -
An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.
por: Borko Amulic, et al.
Publicado: (2009) -
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
por: Vera V Pinto, et al.
Publicado: (2011) -
Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding
por: Kaituo Wang, et al.
Publicado: (2021) -
Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade
por: Jaymin C. Patel, et al.
Publicado: (2017)